Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Case report: Successful treatment of cutaneous leishmaniasis caused by Leishmania aethiopica with liposomal amphothericin B in an immunocompromised traveler returning from Eritrea.

Literature DB >> 21540377

Case report: Successful treatment of cutaneous leishmaniasis caused by Leishmania aethiopica with liposomal amphothericin B in an immunocompromised traveler returning from Eritrea.

Philipp Zanger¹, Ina Kötter, Armin Raible, Tesfaye Gelanew, Gabriele Schönian, Peter G Kremsner.

Abstract

Cutaneous leishmaniasis caused by Leishmania aethiopica is rarely encountered outside disease-endemic areas and there have been no clinical trials evaluating its pharmacotherapy. We describe the treatment of cutaneous leishmaniasis caused by L. aethiopica using liposomal amphothericin B in an immunocompromised traveler returning from Eritrea.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2011 PMID： 21540377 PMCID： PMC3083735 DOI： 10.4269/ajtmh.2011.10-0712

Source DB: PubMed Journal: Am J Trop Med Hyg ISSN： 0002-9637 Impact factor: 2.345

16 in total

1. Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B.

Authors: Patricia Escobar; Sangeeta Matu; Cláudia Marques; Simon L Croft
Journal: Acta Trop Date: 2002-02 Impact factor: 3.112

2. The parasite causing cutaneous leishmaniasis in Ethiopia.

Authors: R S Bray; R W Ashford; M A Bray
Journal: Trans R Soc Trop Med Hyg Date: 1973 Impact factor: 2.184

3. Diffuse cutaneous leishmaniasis in Ethiopia. II. Treatment.

Authors: A D Bryceson
Journal: Trans R Soc Trop Med Hyg Date: 1970 Impact factor: 2.184

4. The epidemiology of cutaneous leishmaniasis in Ethiopia.

Authors: R W Ashford; M A Bray; M P Hutchinson; R S Bray
Journal: Trans R Soc Trop Med Hyg Date: 1973 Impact factor: 2.184

5. Sequence analysis of small subunit ribosomal RNA genes and its use for detection and identification of Leishmania parasites.

Authors: G J van Eys; G J Schoone; N C Kroon; S B Ebeling
Journal: Mol Biochem Parasitol Date: 1992-03 Impact factor: 1.759

6. Genetic variability within the species Leishmania aethiopica does not correlate with clinical variations of cutaneous leishmaniasis.

Authors: G Schönian; H Akuffo; S Lewin; K Maasho; S Nylén; F Pratlong; C L Eisenberger; L F Schnur; W Presber
Journal: Mol Biochem Parasitol Date: 2000-03-05 Impact factor: 1.759

7. Aminosidine and its combination with sodium stibogluconate in the treatment of diffuse cutaneous leishmaniasis caused by Leishmania aethiopica.

Authors: S Teklemariam; A G Hiwot; D Frommel; T L Miko; G Ganlov; A Bryceson
Journal: Trans R Soc Trop Med Hyg Date: 1994 May-Jun Impact factor: 2.184

8. PCR diagnosis and characterization of Leishmania in local and imported clinical samples.

Authors: Gabriele Schönian; Abedelmajeed Nasereddin; Nicole Dinse; Carola Schweynoch; Henk D F H Schallig; Wolfgang Presber; Charles L Jaffe
Journal: Diagn Microbiol Infect Dis Date: 2003-09 Impact factor: 2.803

9. Granulomatous infectious diseases associated with tumor necrosis factor antagonists.

Authors: R S Wallis; M S Broder; J Y Wong; M E Hanson; D O Beenhouwer
Journal: Clin Infect Dis Date: 2004-04-15 Impact factor: 9.079

Review 10. Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe.

Authors: Ioannis D Xynos; Maria G Tektonidou; Dimitrios Pikazis; Nikolaos V Sipsas
Journal: Emerg Infect Dis Date: 2009-06 Impact factor: 6.883

11 in total

Review 1. Interventions for Old World cutaneous leishmaniasis.

Authors: Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal: Cochrane Database Syst Rev Date: 2017-11-17

Review 2. Interventions for Old World cutaneous leishmaniasis.

3. Rhinophyma-Like Cutaneous Leishmaniasis due to Leishmania aethiopica Treated Successfully with Liposomal Amphotericin B.

Authors: Michael Constantin Kirchberger; Stefan Schliep; Christian Bogdan
Journal: Am J Trop Med Hyg Date: 2019-02 Impact factor: 2.345

Review 4. Cutaneous Leishmaniasis Due to Leishmania aethiopica.

Authors: Saskia van Henten; Wim Adriaensen; Helina Fikre; Hannah Akuffo; Ermias Diro; Asrat Hailu; Gert Van der Auwera; Johan van Griensven
Journal: EClinicalMedicine Date: 2019-01-08

5. Surveillance of leishmaniasis cases from 15 European centres, 2014 to 2019: a retrospective analysis.

Authors: Gert Van der Auwera; Leigh Davidsson; Pierre Buffet; Marie-Thérèse Ruf; Marina Gramiccia; Stefania Varani; Carmen Chicharro; Aldert Bart; Gundel Harms; Peter L Chiodini; Hanne Brekke; Florence Robert-Gangneux; Sofia Cortes; Jaco J Verweij; Alessandra Scarabello; Sara Karlsson Söbirk; Romain Guéry; Saskia van Henten; Trentina Di Muccio; Elena Carra; Pieter van Thiel; Martin Vandeputte; Valeria Gaspari; Johannes Blum
Journal: Euro Surveill Date: 2022-01

6. Novel 3-chloro-6-nitro-1H-indazole derivatives as promising antileishmanial candidates: synthesis, biological activity, and molecular modelling studies.

Authors: Mohamed Mokhtar Mohamed Abdelahi; Youness El Bakri; Chin-Hung Lai; Karthikeyan Subramani; El Hassane Anouar; Sajjad Ahmad; Mohammed Benchidmi; Joel T Mague; Jelena Popović-Djordjević; Souraya Goumri-Said
Journal: J Enzyme Inhib Med Chem Date: 2022-12 Impact factor: 5.051

7. In vitro growth inhibitory activity of Medicines for Malaria Venture pathogen box compounds against Leishmania aethiopica.

Authors: Markos Tadele; Solomon M Abay; Peter Asaga; Eyasu Makonnen; Asrat Hailu
Journal: BMC Pharmacol Toxicol Date: 2021-11-16 Impact factor: 2.483